Verbal Analgesia Versus Standard Care for Pain Control in Women With Primary Infertility Undergoing Office Hysteroscopy
1 other identifier
interventional
92
1 country
1
Brief Summary
Office hysteroscopy is a cornerstone in the diagnostic evaluation of infertile women, enabling direct visualization of the uterine cavity for identifying intrauterine pathology. The vaginoscopic ("no-touch") approach, which eliminates the use of a speculum and tenaculum, is increasingly adopted due to improved tolerability, higher success rates, and reduced pain compared to conventional methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 24, 2025
CompletedStudy Start
First participant enrolled
October 20, 2025
CompletedFirst Posted
Study publicly available on registry
January 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2026
CompletedJanuary 8, 2026
January 1, 2026
5 months
September 24, 2025
January 3, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
pain during OH
It will be measured by 0-10 numerical rating scale where 0 indicates no pain and 10 worst pain imaginable
During the procedure (immediately after insertion of hysteroscope, assessed within 5 minutes
Secondary Outcomes (1)
Patient satisfaction
At the end of the visit (within 30 minutes of procedure completion)
Study Arms (2)
Verbal analgesia
EXPERIMENTALProviders will deliver a standardized verbal analgesia script in a calm, slow-paced, supportive tone, synchronized to procedural steps: * Scope introduction (introitus → external os): "You may feel light pressure as the camera enters-keep a slow, steady breath; you are doing well." * Cervical passage (internal os): "A brief pinch or cramp may happen now; it will pass quickly-breathe in slowly, and out." * Uterine entry and distension: "A feeling of fullness is expected; stay with your breath-it eases in moments." * Cavity inspection: "You may notice short waves of cramp; they are normal and brief-you're managing this well." * Withdrawal: "We are nearly finished-slow exhale as we come out. That's it, you did great." Providers will undergo training to ensure fidelity. All participants will receive ibuprofen 600 mg orally one hour before hysteroscopy as standard analgesia.
standard care
SHAM COMPARATORProviders will use neutral, procedural statements without supportive phrasing, e.g., "Starting the camera now," "Passing the cervix," "Entering the uterus," "Inspecting the cavity," "Withdrawing the camera." All participants will receive ibuprofen 600 mg orally one hour before hysteroscopy as standard analgesia.
Interventions
Providers will deliver a standardized verbal analgesia script in a calm, slow-paced, supportive tone, synchronized to procedural steps: * Scope introduction (introitus → external os): "You may feel light pressure as the camera enters-keep a slow, steady breath; you are doing well." * Cervical passage (internal os): "A brief pinch or cramp may happen now; it will pass quickly-breathe in slowly, and out." * Uterine entry and distension: "A feeling of fullness is expected; stay with your breath-it eases in moments." * Cavity inspection: "You may notice short waves of cramp; they are normal and brief-you're managing this well." * Withdrawal: "We are nearly finished-slow exhale as we come out. That's it, you did great." Providers will undergo training to ensure fidelity. All participants will receive ibuprofen 600 mg orally one hour before hysteroscopy as standard analgesia.
Providers will use neutral, procedural statements without supportive phrasing, e.g., "Starting the camera now," "Passing the cervix," "Entering the uterus," "Inspecting the cavity," "Withdrawing the camera.". All participants will receive ibuprofen 600 mg orally one hour before hysteroscopy as standard analgesia.
Eligibility Criteria
You may qualify if:
- o Women aged 18-40 years.
- Diagnosis of primary infertility (failure to conceive after ≥12 months of unprotected intercourse).
- Indication for diagnostic office hysteroscopy.
- Regular menstrual cycles.
You may not qualify if:
- o Secondary infertility.
- Known pelvic infection, cervicitis, or vaginitis.
- Use of analgesics within 8 hours prior to procedure.
- Cervical stenosis, prior failed hysteroscopy, or known uterine anomaly.
- Contraindication to NSAIDs
- Pregnancy or suspected pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
- Aljazeera Hospitalcollaborator
Study Sites (1)
Al Gezeera Hospital
Giza, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
September 24, 2025
First Posted
January 8, 2026
Study Start
October 20, 2025
Primary Completion
March 10, 2026
Study Completion
March 15, 2026
Last Updated
January 8, 2026
Record last verified: 2026-01